Biontech SE Insider Trading
Every director, officer and 10% holder of Biontech SE has to report each trade in its stock within two business days of making it. This is those filings.
BNTX on carbonthat →Purchases and sales
Open-market trades only — the lines where someone chose to buy or sell at the going price.
| Insider | Action | Value |
|---|---|---|
| Ugur SahinChief Executive Officer2026-10-0936.2K shat $95.37 | Sale10b5-1 plan | $3.5M |
| Ugur SahinChief Executive Officer2026-10-0827K shat $92.31 | Sale10b5-1 plan | $2.5M |
| Ugur SahinChief Executive Officer2026-10-0724K shat $95.86 | Sale10b5-1 plan | $2.3M |
| Ugur SahinChief Executive Officer2026-10-0621K shat $96.81 | Sale10b5-1 plan | $2M |
| Ugur SahinChief Executive Officer2026-10-0572K shat $97.23 | Sale10b5-1 plan | $7M |
| Ugur SahinChief Executive Officer2026-09-2834K shat $98.47 | Sale10b5-1 plan | $3.3M |
| Ugur SahinChief Executive Officer2026-09-2527K shat $98.69 | Sale10b5-1 plan | $2.7M |
| Ugur SahinChief Executive Officer2026-09-2439K shat $98.99 | Sale10b5-1 plan | $3.9M |
| Ugur SahinChief Executive Officer2026-09-2330K shat $99.40 | Sale10b5-1 plan | $3M |
| Ugur SahinChief Executive Officer2026-09-2246K shat $100.72 | Sale10b5-1 plan | $4.6M |
| Ugur SahinChief Executive Officer2026-09-2133K shat $97.81 | Sale10b5-1 plan | $3.2M |
| Ugur SahinChief Executive Officer2026-09-1830K shat $96.22 | Sale10b5-1 plan | $2.9M |
| Ugur SahinChief Executive Officer2026-09-1734K shat $98.60 | Sale10b5-1 plan | $3.4M |
| Ugur SahinChief Executive Officer2026-09-1615K shat $96.09 | Sale10b5-1 plan | $1.4M |
| Ugur SahinChief Executive Officer2026-09-1534K shat $96.49 | Sale10b5-1 plan | $3.3M |
| Ugur SahinChief Executive Officer2026-09-1441K shat $99.45 | Sale10b5-1 plan | $4.1M |
| Ugur SahinChief Executive Officer2026-09-1145K shat $96.93 | Sale10b5-1 plan | $4.4M |
| Ugur SahinChief Executive Officer2026-09-1020.5K shat $96.31 | Sale10b5-1 plan | $2M |
| Ugur SahinChief Executive Officer2026-09-0936K shat $97.78 | Sale10b5-1 plan | $3.5M |
| Ugur SahinChief Executive Officer2026-09-0837K shat $99.20 | Sale10b5-1 plan | $3.7M |
| Ugur SahinChief Executive Officer2026-09-0431.5K shat $103.52 | Sale10b5-1 plan | $3.3M |
| Ugur SahinChief Executive Officer2026-09-0345K shat $102.85 | Sale10b5-1 plan | $4.6M |
Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
More on BNTX
Follow Biontech SE (BNTX) by email
New trades in Biontech SE (BNTX) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.